Dementia
Why Do We Grow Older?
Genetic Clock
Limited number of times a cell can divide.
Hayflick Limit: Refers to the maximum number of times a normal somatic mammalian cells can divide before cell division stops.
Telomeres:
Caps at the ends of chromosomes.
They get clipped a little bit every time the cell divides.
Senescence and Primary Aging
Processes of biological aging characterized by a gradual decline in physiological function.
Wear and Tear Theory:
Suggested that aging occurs due to accumulated damage over time from use.
Use It or Lose It:
Vital to maintain brain health through activity.
Involves various factors such as habits, illness, injury, and pollutants leading to cell death and secondary aging.
Effects on Brain Development:
Built-in aging processes vs. plasticity.
Level of activity has significant impacts.
Exercise:
Known to release Brain-Derived Neurotrophic Factor (BDNF), which plays a crucial role in maintaining and supporting neuronal plasticity.
Avoiding Disease: Importance of a healthy lifestyle for prevention.
Alzheimer's Disease
A. Characteristics
Memory Loss:
Recognition troubles (agnosias): difficulty in recognizing familiar faces or objects.
Loss of ability to remember new information.
Judgment and Planning Suffers:
Challenges in reasoning and abstract thought.
Mood Swings and Confusion:
Symptoms include wandering behavior and sundowning (confusion or agitation that occurs in the late afternoon and evening).
Paranoia, Hallucinations, Delusions:
Increased social withdrawal and alterations in behavior.
Difficulty Learning:
This includes deficits in language (aphasias) and poor impulse control.
Physical Decline:
Occurs particularly in the middle and late stages of the disease.
B. Prevalence, Onset, and Progression
Onset:
Typically begins in mid to late 60s.
Early onset Alzheimer's can occur before the age of 65.
Progression:
Average duration of 3-5 years, but can range from 10 to 20 years depending on various factors.
Demographics:
Women account for 2/3 of cases.
2024 Prevalence Estimates:
Estimated 7 million patients in the U.S. aged 65 and older.
Prevalence rates:
Overall: 10.9%
Ages 75-84: 13.8%
Ages 85 and above: 34.6%.
C. Diagnosis
Autopsy
Plaques and tangles are key indicators:
Plaques: Consist of beta-amyloid protein.
Tangles: Composed of tau protein, causing a mixed-up appearance of brain cells.
Mental Status Exam:
Approximately 80% accurate for diagnosing Alzheimer's.
APOE-4:
Protein associated with an increased risk of developing dementia.
Spinal Fluid and Eye Exams:
These may provide new avenues for diagnostic testing.
PET and MRI Scans:
Used to observe changes in brain mass and overall structure.
Blood Test:
Utilizes biomarkers and family history to assist in diagnosis.
Causes
Diseased Brain:
Key characteristic features:
Beta-Amyloid Plaque and Neurofibrillary Tangles.
Affected areas often include the hippocampus crucial for memory.
Acetylcholine levels drop significantly in dementia (90% drop in concentration).
Reduction of connections (40% drop in number).
Down Syndrome patients have a 2-3x increased risk.
Genetic Factors:
Risk increases with age; earlier onset correlates with hereditary factors.
Known gene mutations that confer risk include APP, PS1, PS2.
Other Risk Factors:
Possible connections to aluminum exposure.
Previous head trauma, heart disease, high cholesterol, and pollution exposure may increase risk.
Other factors include sleep quality, level of activity, education level, social interaction, and personality traits.
E. Prevention and Treatment
Current Status:
No known cures exist.
Medication Options:
Ibuprofen, estrogen therapy, and vitamin E may provide some benefits.
Mental Fitness:
Engaging in cognitive exercises is critical for cognitive health.
Lifestyle Modifications:
Emphasizes the importance of diet, exercise, and adequate sleep.
Assisted Living:
Therapeutic practices to support patients, including validation theory approaches.
Validation Theory:
Incorporates therapeutic fibbing to support patients emotionally and mentally, providing comfort as they deal with cognitive decline.